Skip to content
← Back to all writing
Ankylosing SpondylitisView series

Article 2 of 5 · The Four Pillars

Ankylosing Spondylitis

Treating Ankylosing Spondylitis in 2026

23 min readBeginner level

A patient-friendly, evidence-based guide to AS and axial spondyloarthritis treatment in 2026: NSAIDs, biologics, IL-17 inhibitors, JAK inhibitors, biosimilars, switching, safety checks, and the questions to bring your rheumatologist.

Treating Ankylosing Spondylitis in 2026

If you're reading this, there's a good chance you or someone you love has been diagnosed with ankylosing spondylitis. Maybe you're sitting in a waiting room. Maybe you've just been handed a prescription with a name you can't pronounce. Maybe you've been on three drugs already and you're trying to figure out what comes next.

Sign in or create a free account

A free reader account lets you read two articles a day, save pieces for later, and join the conversation.

Continue with a free account

Free account · no credit card · or go unlimited for CAD $20/month. JavaScript off? The button opens the standard sign-in page.

Auto-renews monthly · Plus applicable taxes